Nl-Fr

Panel Discussion on Usage of Biologics in Uveitis Therapy

Course
Wednesday 25 June 2025, 12:00 - 13:00, Gávea A (400)
Moderators
Piergiorgio NERI, Eric SUHLER
12:00PANELISTS : Usage of Biologics in Uveitis Therapy MATSUMIYA W
12:00PANELISTS : Usage of Biologics in Uveitis Therapy MISEROCCHI E
12:00PANELISTS : Usage of Biologics in Uveitis Therapy VASCONCELOS-SANTOS D
12:00PANELISTS : Usage of Biologics in Uveitis Therapy UY H
12:00PANELISTS : Usage of Biologics in Uveitis Therapy YOO WS

DISCUSSION AREAS
 
When to consider the use of biologics
  • First-line biologic treatment ?
  • Second- or third-line therapy ?
Which agent to use as first-line biologic therapy? 
  • Anti-TNF%u03B1 
  • Anti-IL6
  • Others?
How to prescribe biologics 
  • Pretreatment screening
  • Dosage and frequency of treatment 
  • Monotherapy vs Combined therapy
  • Regular monitoring of drug level and anti-drug antibodies?
Special situations 
  • Elective surgery
  • Vaccinations 
  • Pregnancy
  • Sickness/Severe infection
Treatment failure
  • Loss of efficacy: role of drug level and anti-drug antibodies
  • When to check drug level and anti-drug antibodies and how to interpret results
  • How dosage and frequency of treatment can be adjusted
  • What is the next best option if anti-TNF%u03B1 fails: switching within or between classes?
When to stop?
  •  How long after quiescence?